S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The only accurate crypto trading system I know … (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Urgent alert: open this for a huge profit potential (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
SHOCKING Crypto Leak… (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The only accurate crypto trading system I know … (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Urgent alert: open this for a huge profit potential (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
SHOCKING Crypto Leak… (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The only accurate crypto trading system I know … (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Urgent alert: open this for a huge profit potential (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
SHOCKING Crypto Leak… (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The only accurate crypto trading system I know … (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Urgent alert: open this for a huge profit potential (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
SHOCKING Crypto Leak… (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial
OTCMKTS:INVVY

Indivior (INVVY) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)
Free INVVY Stock Alerts
$21.85
-0.40 (-1.82%)
(As of 06/9/2023)
Compare
Today's Range
$21.64
▼
$21.85
50-Day Range
$21.85
▼
$21.85
52-Week Range
$14.76
▼
$35.50
Volume
8,100 shs
Average Volume
3,825 shs
Market Capitalization
$3.01 billion
P/E Ratio
20.81
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisHeadlines
INVVY stock logo

About Indivior Stock (OTCMKTS:INVVY)

Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom.

INVVY Stock Price History

INVVY Stock News Headlines

March 6, 2024 | finance.yahoo.com
Zacks.com featured highlights Modine Manufacturing, Indivior and Interface
February 22, 2024 | marketwatch.com
Indivior Shares Jump on Possible U.S. Listing, Swing to Pretax Profit
April 19, 2024 | Altimetry (Ad)
Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
February 22, 2024 | msn.com
Indivior shares soar as pharma firm ponders primary listing in the US
February 22, 2024 | msn.com
Drug maker Indivior considers ditching primary UK listing for US
February 22, 2024 | uk.finance.yahoo.com
UPDATE 1-UK-listed Indivior plans shifting to US bourses by summer
February 22, 2024 | ca.news.yahoo.com
Drugmaker Indivior consults on moving primary listing from London to US
February 22, 2024 | finance.yahoo.com
Indivior plans shifting primary listing to U.S.
April 19, 2024 | Altimetry (Ad)
Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
February 22, 2024 | ft.com
Indivior aims to move primary listing from London to New York
February 22, 2024 | msn.com
Indivior plans primary US listing in another hit to London’s flagging equity market
January 16, 2024 | thetimes.co.uk
Indivior boss brings promise of a pick-me-up for staff
December 20, 2023 | marketwatch.com
Indivior Resolves Patent Disputes With Actavis
December 5, 2023 | lse.co.uk
Indivior and Reckitt land legal boost in UK Suboxone claim
December 5, 2023 | marketwatch.com
Indivior Says UK High Court Strikes Claims Against It and Reckitt Benckiser
November 17, 2023 | lse.co.uk
Indivior to keep Scopia's Jerome Lande on board as agreement extended
November 17, 2023 | marketwatch.com
Indivior Extends Relationship, Board Representation of Major Shareholder
November 17, 2023 | lse.co.uk
UPDATE: Indivior plans up to USD100 million share buyback programme
November 17, 2023 | marketwatch.com
Indivior to Begin $100 Mln Share Buyback
November 9, 2023 | uk.finance.yahoo.com
Indivior Announces Q3 2023 Financial Results
November 9, 2023 | lse.co.uk
Indivior swings to quarterly loss on costs despite strong sales
November 9, 2023 | marketwatch.com
Indivior Swings to Pretax Loss on Higher Costs; Backs Revenue View
October 24, 2023 | reuters.com
Indivior to pay $385 mln to settle Suboxone claims by direct purchasers
October 23, 2023 | thetimes.co.uk
Indivior freed up to fight global crisis
October 23, 2023 | reuters.com
UPDATE 1-Indivior to pay $385 mln to end Suboxone monopoly lawsuits
October 23, 2023 | msn.com
Indivior to pay $385 million to end final Suboxone monopoly lawsuits
October 23, 2023 | msn.com
Indivior settles anti-trust lawsuits worth £316m
See More Headlines
Receive INVVY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Indivior and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:INVVY
Previous Symbol
NASDAQ:INVVY
CUSIP
N/A
CIK
1625297
Web
www.indivior.com
Phone
804-379-1090
Fax
804-379-1215
Employees
800
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
20.81
Forward P/E Ratio
17.62
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$791 million
Price / Sales
3.81
Cash Flow
$1.15 per share
Price / Cash Flow
18.94
Book Value
$1.45 per share
Price / Book
15.07

Miscellaneous

Outstanding Shares
137,880,000
Free Float
N/A
Market Cap
$3.01 billion
Optionable
Not Optionable
Beta
0.35
5G Stocks: The Path Forward is Profitable Cover
5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mark Crossley
    Chief Executive Officer & Executive Director
  • Ryan Preblick
    Chief Financial Officer & Executive Director
  • Christian Heidbreder
    Chief Scientific Officer
  • Cynthia Cetani
    Chief Compliance & Integrity Officer
  • Nina DeLorenzo
    Chief Global Impact Officer

Key Competitors

View All Competitors

INVVY Stock Analysis - Frequently Asked Questions

How have INVVY shares performed in 2024?

Indivior's stock was trading at $21.8455 on January 1st, 2024. Since then, INVVY shares have increased by 0.0% and is now trading at $21.8455.
View the best growth stocks for 2024 here.

How do I buy shares of Indivior?

Shares of INVVY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:INVVY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends